Skip to main content

Advertisement

Table 6 Comparison of pre- and post-therapy laboratory parameters

From: Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

Laboratory parameters Baseline Post-therapy P value
Hematotoxicity
 Hemoglobin, g/dL 12.9 ± 1.5 12.5 ± 1.5 0.477
 Platelets, 100,000/mm3 278.3 ± 92.2 256 ± 85.7 0.547
 Leukocytes, cells/mm3 7749 ± 2121 7435 ± 2561 0.223
Nephrotoxicity
 Blood urea, mg/dL 20.7 ± 7.4 23.35 ± 11.4 0.407
 Serum creatinine, mg/dL 0.84 ± 0.2 0.82 ± 0.2 0.605
 GFR, mL/min/1.73 m2 BSA 93.8 ± 25.2 92.7 ± 24.8 0.984
Hepatotoxicity
 Serum bilirubin, mg/dL 0.57 ± 0.13 0.51 ± 0.45 0.442
  1. All parameters are explained as mean ± SD